Pharmacokinetic and statistical analysis in bioequivalence while maintaining the blind [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2023-02-13 16:07 (226 d 06:16 ago) – Posting: # 23461
Views: 1,189

Hi Imph,

❝ In bioequivalence studies, is there a way to keep the blind on the analysts in charge of the pharmacokinetic and statistical analysis ? If so, is there a possibility of launching an NCA and bioequivalence analysis on the Phoenix WinNonlin software while maintaining the blind.

What an interesting and atypical question. Thank you.
I do no know about WinNonlin at all, but this detail aside the matter poses no particular difficulties. You could have an automated process started by a project manager (or whoever ) where stats software queries the PK listing along with the rand. code from separate locations, processes the data and saves the outcome without the statistical or the PK staff even knowing it has taken place.
If WNL can be run from command line (why shouldn't it?) then all this is will be fairly easy to do:

Person A saves bioanalytical data in folder X. Write access only.
Person B saves Rand Code in folder Y. Write access only.
Person C shell executes WNL (read access to X and Y) to reconcile PK data with RC, and run the analyses and saving it in location Z while revoking A+B writing credentials (write access).

This could be a very, very safe and advantageous approach (one that even could be combined with signal detection etc). But of course if there is an issue with the files and WNL is stuck, then some intervention could be needed.

Pass or fail!

Complete thread:

UA Flag
 Admin contact
22,761 posts in 4,775 threads, 1,628 registered users;
19 visitors (0 registered, 19 guests [including 7 identified bots]).
Forum time: 23:24 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz